- Home
- AGFY vs APLT Comparison
AGFY vs APLT Comparison
Compare AGFY & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGFY
- APLT
- Stock Information
- Founded
- AGFY 2016
- APLT 2016
- Country
- AGFY United States
- APLT United States
- Employees
- AGFY N/A
- APLT N/A
- Industry
- AGFY Military/Government/Technical
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- AGFY Consumer Discretionary
- APLT Health Care
- Exchange
- AGFY Nasdaq
- APLT Nasdaq
- Market Cap
- AGFY 41.3M
- APLT 44.0M
- IPO Year
- AGFY 2021
- APLT 2019
- Fundamental
- Price
- AGFY $25.43
- APLT $0.48
- Analyst Decision
- AGFY
- APLT Buy
- Analyst Count
- AGFY 0
- APLT 7
- Target Price
- AGFY N/A
- APLT $6.10
- AVG Volume (30 Days)
- AGFY 16.2K
- APLT 2.5M
- Earning Date
- AGFY 08-13-2025
- APLT 08-06-2025
- Dividend Yield
- AGFY N/A
- APLT N/A
- EPS Growth
- AGFY N/A
- APLT N/A
- EPS
- AGFY N/A
- APLT N/A
- Revenue
- AGFY $10,218,000.00
- APLT $265,000.00
- Revenue This Year
- AGFY N/A
- APLT $415.60
- Revenue Next Year
- AGFY N/A
- APLT $1,323.96
- P/E Ratio
- AGFY N/A
- APLT N/A
- Revenue Growth
- AGFY 9.42
- APLT N/A
- 52 Week Low
- AGFY $2.71
- APLT $0.30
- 52 Week High
- AGFY $84.44
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- AGFY 52.51
- APLT 60.46
- Support Level
- AGFY $24.11
- APLT $0.44
- Resistance Level
- AGFY $29.34
- APLT $0.55
- Average True Range (ATR)
- AGFY 1.90
- APLT 0.04
- MACD
- AGFY 0.21
- APLT 0.01
- Stochastic Oscillator
- AGFY 37.03
- APLT 68.60
About AGFY Agrify Corporation
Agrify Corp is a developer of branded inventive solutions for the cannabis and hemp industries. Its Senorita brand offers consumers hemp-derived tetrahydrocannabinol (THC) beverages that mirror cocktails like a margarita - in three flavors - classic Lime Jalapeno Margarita, Mango Margarita, and Paloma. In addition to beverages, Agrify has also historically been a provider of inventive cultivation and extraction solutions for the cannabis industry. Its comprehensive extraction product line, which includes hydrocarbon, alcohol, solventless, post-processing, and lab equipment, empowers producers to maximize the quantity and quality of extract required for premium concentrates.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.